Single-Patient study probes heart Drug's immediate effect
NCT ID NCT06534671
Summary
This study tested whether a single dose of the blood pressure medication diltiazem could quickly shorten a dangerous long QT interval in adults with Jervell and Lange-Nielsen syndrome, a rare genetic heart condition. It involved just one participant who received the drug through an IV during a single visit, with heart measurements taken immediately afterward. The goal was to gather basic knowledge about how this existing drug might affect this specific syndrome.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JERVELL AND LANGE NIELSEN SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.